Agency Information Collection Activities: Proposed Collection; Comment Request, 9136-9137 [06-1597]
Download as PDF
<![CDATA[
9136
Federal Register / Vol. 71, No. 35 / Wednesday, February 22, 2006 / Notices
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions; (3) Ways
to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Christy Thomsen,
Director, Office of Communications and
Public Liaison, NCCAM, 31 Center
Drive, Room 2B11, Bethesda, MD
20892–2182; or fax your request to 301–
402–4741; or e-mail
thomsenc@mail.nih.gov. Ms. Thomsen
can be contacted by telephone at 301–
451–8876.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: February 14, 2006.
Christy Thomsen,
Director, Office of Communications and
Public Liaison, National Center for
Complementary and Alternative Medicine,
National Institutes of Health.
[FR Doc. E6–2507 Filed 2–21–06; 8:45 am]
Delegations of Authority
All delegations and redelegations of
authority to officers and employees of
NIH that were in effect immediately
prior to the effective date of this
amendment and are consistent with this
amendment shall continue in effect,
pending further redelegation.
BILLING CODE 4167–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PROD1PC66 with NOTICES
Statement of Organization, Functions,
and Delegations of Authority
Part N, National Institutes of Health,
of the Statement of Organization,
Functions, and Delegations of Authority
for the Department of Health and
Human Services (HHS) (40 FR 22859,
May 27, 1975, as amended most recently
at 69 FR 64081, November 3, 2004, and
redesignated from Part HN as Part N at
60 FR 56606, November 9, 1995), is
amended as set forth below to reflect the
reorganization of the National Human
Genome Research Institute, Division of
Intramural Research, by establishing (1)
the Molecular Neurogenetics Section in
the Medical Genetics Branch and (2) the
VerDate Aug<31>2005
14:35 Feb 21, 2006
Jkt 208001
Vascular Biology Section in the Genome
Technology Branch. The sections are
transferring from, respectively, the
National Heart, Lung, and Blood
Institute and the National Institute of
Mental Health.
Section N–B, Organization and
Functions, under the heading National
Human Genome Research Institute (N4,
formerly HN4), Division of Intramural
Research (N45, formerly HN45) is
amended as follows:
(1) In the Genome Technology Branch
(N455, formerly HN455), immediately
after the paragraph on Genomic
Functional Analysis Section (N4556,
formerly HN 4556), insert the following:
Vascular Biology Section (N4557,
formerly HN 4557). Conducts clinical
and laboratory investigations in the
molecular mechanisms of
cardiovascular disease including
vascular cell biology, gene therapy, and
cell cycle regulation of vascular cells.
(2) In the Medical Genetics Branch
(N456, formerly HN456), immediately
after the paragraph on Vertebrate
Embryology Section (N4567, formerly
HN4567), insert the following:
Molecular Neurogenetics Section
(N4568, formerly HN 4568). (1)
Conducts clinical and basic research
into the factors contributing to the
phenotypic variation observed in
monogenic diseases, using Gaucher
disease as a prototype disorder; (2)
investigates the relationship between
Gaucher disease and parkinsonism; and
(3) explores new therapeutic approaches
for Gaucher disease.
Dated: February 8, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06–1642 Filed 2–21–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the paperwork
Reduction Act of 1995 concerning
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (OMB NO. 0930–
0158)—Revision
SAMHSA’s Mandatory Guidelines for
Federal Workplace Drug Testing
Programs will request OMB approval for
the Federal Drug Testing Custody and
Control Form for Federal agency and
federally regulated drug testing
programs which must comply with the
HHS Mandatory Guidelines for Federal
Workplace Drug Testing Programs (69
FR 19644) dated April 13, 2004, and for
the information provided by laboratories
for the National Laboratory Certification
Program (NLCP).
The Federal Drug Testing Custody
and Control Form is used by all Federal
agencies and employers regulated by the
Department of Transportation to
document the collection and chain of
custody of urine specimens at the
collection site, for laboratories to report
results, and for Medical Review Officers
to make a determination. The Federal
Drug Testing Custody and Control Form
approved by OMB three years ago is
being resubmitted for OMB approval
without any revision.
Prior to an inspection, a laboratory is
required to submit specific information
regarding its laboratory procedures.
Collecting this information prior to an
inspection allows the inspectors to
thoroughly review and understand the
laboratory’s testing procedures before
arriving at the laboratory.
The NLCP application form has not
been revised compared to the previous
form.
E:\FR\FM\22FEN1.SGM
22FEN1
Federal Register / Vol. 71, No. 35 / Wednesday, February 22, 2006 / Notices
The annual total burden estimates for
the Federal Drug Testing Custody and
Control Form, the NLCP application, the
NLCP inspection checklist, and NLCP
recordkeeping requirements are shown
in the following table.
Burden/
response
(hrs.)
Form/respondent
9137
Number of
responses
Total annual
burden
(hrs.)
Custody and Control Form:
Donor ........................................................................................................................
Collector ....................................................................................................................
Laboratory .................................................................................................................
Medical Review Officer .............................................................................................
Laboratory Application .....................................................................................................
Laboratory Inspection Checklist ......................................................................................
Laboratory Recordkeeping ..............................................................................................
.08
.07
.05
.05
3.00
3.00
250.00
7,096,000
7,096,000
7,096,000
7,096,000
3
100
50
567,680
496,720
354,800
354,800
9
300
12,500
Total ...................................................................................................................
............................
............................
1,786,809
Dated: February 14, 2006.
Anna Marsh,
Director, Office of Program Services.
[FR Doc. 06–1597 Filed 2–21–06; 8:45 am]
State and Tribal Assistance Grants
(STAG) will also fund water and
wastewater related infrastructure. EPA
is acting as a cooperating agency for this
process.
DATES: Comments Due Date: Comments
due no later than March 24, 2006.
Comments on the FEIS/FEIR should be
addressed to the contact person listed
below.
BILLING CODE 4162–20–M
FOR FURTHER INFORMATION CONTACT:
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 7–1044, One Choke Cherry Road,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–4912–N–17]
Notice of Availability of a Final
Environmental Impact Statement for
the Development of Stillwater
Business Park, City of Redding, CA
Office of the Assistant
Secretary for Community Planning and
Development, HUD.
ACTION: Notice.
cprice-sewell on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: HUD gives notice to the
public, agencies, and Indian tribes that
the City of Redding, CA, makes
available to the public for comment the
Final Environmental Impact Statement/
Final Environmental Impact Report
(FEIS/FEIR) for the Stillwater Business
Park project located in Redding CA. The
City of Redding, CA has prepared the
FEIS/FEIR under its authority as the
Responsible Entity for compliance with
the National Environmental Policy Act
(NEPA) in accordance with 24 CFR 58.4,
and under its authority as lead agency
in accordance with the California
Environmental Quality Act (CEQA).
This notice is given in accordance with
the Council on Environmental Quality
regulations at 40 CFR parts 1500–1508.
A HUD Economic Development
Initiative (EDI) special purpose grant
would be used for the project.
Environmental Protection Agency (EPA)
VerDate Aug<31>2005
14:35 Feb 21, 2006
Jkt 208001
Nathan Cherpeski, City of Redding, 777
Cypress Ave., Redding, CA 96001, at
(530) 225–4519 or
ncherpeski@ci.redding.ca.us. The FEIS/
FEIR is available on the Internet and can
be viewed or downloaded at: https://
ci.redding.ca.us/cm/major_pr/
still_buspk.html. Copies of the DEIS and
Draft EIS/EIR are also available for
viewing at the following locations:
City of Redding, Permit Center, 777
Cypress Ave., Redding, CA 96001.
City of Anderson Planning Department,
1887 Howard Street, Anderson, CA
96007.
Shasta County Library—Anderson
Branch, 3200 West Center, Anderson,
CA 96007.
Shasta County Department of Resource
Management, Planning Division, 1855
Placer Street, Redding, CA 96001.
Shasta County Library, 1855 Shasta
Street, Redding, CA 96001.
SUPPLEMENTARY INFORMATION: A Notice
of Intent to prepare a draft EIS was
published May 11, 2004. Scoping
meetings were held on April 4, 2001,
August 12, 2003, and June 2, 2004, to
determine the issues for the EIS/EIR. A
DEIS/DEIR was completed in May 2005.
The DEIS/DEIR was the subject of
public comments, both oral and written,
provided by agencies, interested groups,
and individuals, at a public hearing on
April 12, 2005, and during the DEIS
public comment period which extended
from March 18, 2005, through May 2,
2005.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
As a result of comments received and
after meetings with EPA, USFWS,
USACOE, and the California
Department of Fish and Game, the City
of Redding circulated a Supplemental
Draft Environmental Impact Statement
(SDEIS/DEIR) with a comment period
from September 30, 2005, through
November 14, 2005. A public open
house was held October 26, 2005.
Significant changes were made to the
preferred alternative in the SDEIR/DEIR.
Those changes are reflected in the
preferred alternative described in the
FEIS/FEIR. Developable acreage has
been reduced and the size of the open
space preserve has increased.
The preferred alternative is the
development of a medium-to-large
parcel business park through the
acquisition of land, construction of
major infrastructure components, and
the provision of public services and
utilities to serve the development. The
City of Redding is proposing the
development of the area east and
northeast of the Municipal Airport in
Redding, California. The proposed
action study area is located on the
Enterprise and Cottonwood, California
7.5-minute USGS quadrangles,
Township 31 North, Range 4 West,
Sections 2, 3, 10, 14, 15, 22, 23, 26, 34,
and 35. A portion of the proposed
location is classified as industrial and a
portion as park under the Redding
General Plan, adopted in 2000. The
purpose and need for this project is to
increase the activity of contributory
economic sectors by constructing a
medium to large parcel business park
within the City of Redding sphere of
influence capable of attracting and
accommodating diverse business and
industrial users.
The original proposal called for an
approximate 687-acre business park
consisting of 383 acres of developable
land for a total of 4,410,400 sq. ft. of
improvements for professional offices
and industrial users. The preferred
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 71, Number 35 (Wednesday, February 22, 2006)]
[Notices]
[Pages 9136-9137]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-1597]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with Section 3506(c)(2)(A) of the paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Mandatory Guidelines for Federal Workplace Drug
Testing Programs (OMB NO. 0930-0158)--Revision
SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing
Programs will request OMB approval for the Federal Drug Testing Custody
and Control Form for Federal agency and federally regulated drug
testing programs which must comply with the HHS Mandatory Guidelines
for Federal Workplace Drug Testing Programs (69 FR 19644) dated April
13, 2004, and for the information provided by laboratories for the
National Laboratory Certification Program (NLCP).
The Federal Drug Testing Custody and Control Form is used by all
Federal agencies and employers regulated by the Department of
Transportation to document the collection and chain of custody of urine
specimens at the collection site, for laboratories to report results,
and for Medical Review Officers to make a determination. The Federal
Drug Testing Custody and Control Form approved by OMB three years ago
is being resubmitted for OMB approval without any revision.
Prior to an inspection, a laboratory is required to submit specific
information regarding its laboratory procedures. Collecting this
information prior to an inspection allows the inspectors to thoroughly
review and understand the laboratory's testing procedures before
arriving at the laboratory.
The NLCP application form has not been revised compared to the
previous form.
[[Page 9137]]
The annual total burden estimates for the Federal Drug Testing
Custody and Control Form, the NLCP application, the NLCP inspection
checklist, and NLCP recordkeeping requirements are shown in the
following table.
----------------------------------------------------------------------------------------------------------------
Burden/ Number of Total annual
Form/respondent response (hrs.) responses burden (hrs.)
----------------------------------------------------------------------------------------------------------------
Custody and Control Form:
Donor................................................. .08 7,096,000 567,680
Collector............................................. .07 7,096,000 496,720
Laboratory............................................ .05 7,096,000 354,800
Medical Review Officer................................ .05 7,096,000 354,800
Laboratory Application.................................... 3.00 3 9
Laboratory Inspection Checklist........................... 3.00 100 300
Laboratory Recordkeeping.................................. 250.00 50 12,500
-----------------------------------------------------
Total............................................. ................ ................ 1,786,809
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 7-1044, One Choke Cherry Road, Rockville, MD 20857. Written
comments should be received within 60 days of this notice.
Dated: February 14, 2006.
Anna Marsh,
Director, Office of Program Services.
[FR Doc. 06-1597 Filed 2-21-06; 8:45 am]
BILLING CODE 4162-20-M
